Answers are grounded in this paper and cite their sources.
The results show that a classifier using multiple SNPs can predict treatment outcome more reliably than single-SNP models. This multi-SNP classifier should be tested on data from newly diagnosed epilepsy populations to determine its broad clinical validity. Our method to developing a multi-SNP classifier could be applied to pharmacogenomic studies of other complex diseases.
No takes yet. Share an insight, caveat, or question.
Petrovski et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: